Wells Fargo & Company Fate Therapeutics Inc Transaction History

Wells Fargo & Company

  • $407 Billion
  • Q2 2024

A detailed history of Wells Fargo & Company transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Wells Fargo & Company holds 57,252 shares of FATE stock, worth $145,992. This represents 0.0% of its overall portfolio holdings.

Number of Shares
57,252
Previous 41,013 39.59%
Holding current value
$145,992
Previous $301,000 37.87%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$3.26 - $7.08 $52,939 - $114,972
16,239 Added 39.59%
57,252 $187,000
Q1 2024

May 10, 2024
BUY
$3.54 - $8.35 $9,462 - $22,319
2,673 Added 6.97%
41,013 $301,000
Q4 2023

Feb 09, 2024
BUY
$1.65 - $3.94 $6,657 - $15,897
4,035 Added 11.76%
38,340 $143,000
Q3 2023

Nov 13, 2023
SELL
$2.02 - $5.04 $359,194 - $896,207
-177,819 Reduced 83.83%
34,305 $72,000
Q2 2023

Aug 15, 2023
SELL
$4.76 - $6.59 $270,382 - $374,331
-56,803 Reduced 21.12%
212,124 $1.01 Million
Q1 2023

May 12, 2023
BUY
$4.24 - $11.12 $925,320 - $2.43 Million
218,236 Added 430.52%
268,927 $1.53 Million
Q4 2022

Feb 13, 2023
BUY
$9.86 - $23.83 $40,140 - $97,011
4,071 Added 8.73%
50,691 $511,000
Q3 2022

Nov 14, 2022
BUY
$21.04 - $36.06 $21,271 - $36,456
1,011 Added 2.22%
46,620 $1.05 Million
Q2 2022

Aug 12, 2022
SELL
$17.78 - $42.39 $1.72 Million - $4.1 Million
-96,789 Reduced 67.97%
45,609 $1.13 Million
Q1 2022

May 16, 2022
SELL
$29.67 - $60.28 $1.18 Million - $2.4 Million
-39,747 Reduced 21.82%
142,398 $5.52 Million
Q4 2021

Feb 14, 2022
SELL
$47.84 - $64.34 $9.52 Million - $12.8 Million
-198,946 Reduced 52.2%
182,145 $10.7 Million
Q3 2021

Nov 15, 2021
BUY
$59.27 - $95.73 $3.22 Million - $5.2 Million
54,322 Added 16.62%
381,091 $22.6 Million
Q2 2021

Aug 16, 2021
BUY
$67.25 - $92.52 $7.99 Million - $11 Million
118,761 Added 57.09%
326,769 $28.4 Million
Q1 2021

May 13, 2021
SELL
$72.16 - $117.4 $1.42 Million - $2.32 Million
-19,723 Reduced 8.66%
208,008 $17.1 Million
Q4 2020

Feb 09, 2021
SELL
$38.09 - $100.95 $773,798 - $2.05 Million
-20,315 Reduced 8.19%
227,731 $20.7 Million
Q3 2020

Nov 05, 2020
SELL
$30.41 - $40.5 $2.91 Million - $3.88 Million
-95,754 Reduced 27.85%
248,046 $9.91 Million
Q2 2020

Aug 13, 2020
SELL
$20.21 - $35.23 $1.61 Million - $2.81 Million
-79,851 Reduced 18.85%
343,800 $11.8 Million
Q1 2020

May 14, 2020
BUY
$17.28 - $31.88 $7.32 Million - $13.5 Million
423,651 New
423,651 $9.41 Million

Others Institutions Holding FATE

# of Institutions
185
Shares Held
123M
Call Options Held
15K
Put Options Held
14K
View Full List

About FATE THERAPEUTICS INC

FATE Quotes by TradingView
  • Ticker FATE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,000,304
  • Market Cap $247M
  • Description
  • Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...
More about FATE
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email